- Home
- CMA vs HSIC Comparison
CMA vs HSIC Comparison
Compare CMA & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMA | HSIC |
|---|---|---|
| Founded | 1849 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 8.8B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | CMA | HSIC |
|---|---|---|
| Price | $88.84 | $77.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 21 | 14 |
| Target Price | $71.45 | ★ $76.50 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 01-21-2026 | 11-04-2025 |
| Dividend Yield | ★ 3.22% | N/A |
| EPS Growth | 30.50 | ★ 30.70 |
| EPS | ★ 5.23 | 3.17 |
| Revenue | $3,234,000,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $6.42 | $5.35 |
| Revenue Next Year | $3.03 | $3.34 |
| P/E Ratio | ★ $16.88 | $24.41 |
| Revenue Growth | 2.31 | ★ 3.51 |
| 52 Week Low | $48.12 | $60.56 |
| 52 Week High | $90.44 | $82.49 |
Technical Indicators
Market Signals| Indicator | CMA | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 72.11 | 67.52 |
| Support Level | $87.54 | $76.27 |
| Resistance Level | $89.16 | $77.74 |
| Average True Range (ATR) | 1.75 | 1.31 |
| MACD | 0.14 | 0.04 |
| Stochastic Oscillator | 83.37 | 91.42 |
Price Performance
Historical ComparisonAbout CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.